← Back to Research Reports
BA.LSE September 23, 2026 Sell

BAE Systems (BA.LSE): Great fundamentals but a premium valuation

BAE Systems plc is a UK-based aerospace and defense company that provides defense, aerospace, and security solutions across the United States, the United Kingdom, the Middle East, Australia, Saudi Arabia, Europe, and other international markets. Its operations span five segments: Electronic Systems, Platforms & Services, Air, Maritime, and Cyber & Intelligence, covering military electronics, combat vehicles, ships, submarines, cyber security, and related support services. The name matters for investors because it combines large-scale defense exposure with resilient demand, and FY2025 revenue rose to GBP 28.3bn. Profitability is healthy, with FY2025 EBITDA of GBP 3.77bn, an operating margin of 9.7%, a net margin of 7.2%, and ROE of 18.6%. Cash generation is also supporting the equity case, with FY2025 operating cash flow of GBP 3.30bn and free cash flow of GBP 2.38bn. The stock is not cheap on trailing metrics at 28.7x earnings and 4.8x book, but the forward P/E of 20.8x and higher next-year EPS estimate suggest the setup is tied to continued execution and defense spending resilience.

šŸ“‹ Actions

No actions yet for this report.

ā–¶

šŸ’” Key Insights / Thesis

  • BAE Systems combines defensive end-markets with solid operating momentum: FY2025 revenue rose to GBP 28.3bn, with quarterly revenue growth of 7.7% YoY and quarterly earnings growth of 5.6% YoY, supporting the case that demand remains resilient across its defense franchises.
  • Profitability is healthy and improving at scale, with FY2025 EBITDA of GBP 3.77bn, operating margin of 9.7%, and net margin of 7.2%; ROE of 18.6% suggests the business is still generating attractive returns despite the capital intensity of the sector.
  • Cash generation remains a key support for the equity story: FY2025 operating cash flow was GBP 3.30bn and free cash flow GBP 2.38bn, backing the dividend and helping offset a still-levered balance sheet.
  • Balance sheet risk is manageable but worth monitoring, with net debt of GBP 5.61bn, long-term debt of GBP 7.19bn, and total liabilities of GBP 25.7bn against equity of GBP 11.8bn; working capital was slightly negative, so execution on cash conversion remains important.
  • Valuation is not cheap: trailing P/E is 28.7x and price/book is 4.8x, while EV/EBITDA is 14.8x; however, the forward P/E of 20.8x and upward EPS estimates to 0.9585 for next year indicate investors are paying for continued earnings growth.
  • The stock’s near-term catalysts are continued defense spending, backlog conversion, and margin discipline, with the latest consensus EPS estimate up 14.1% for 2027 and revisions over the last 30 days skewing positive.
  • Key risks are valuation compression if growth moderates, leverage/interest expense sensitivity, and any slowdown in contract execution or government procurement timing; the low beta reading also underscores that the shares may trade more on fundamentals and sentiment than broad market moves.
ā–¶

🧩 Gemini Research